Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-07

Clinical Trial Update: Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating levetiracetam (Keppra) for acute alcohol-related seizure control was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Seizure, Alcohol Related | Phase 2 | Status: WITHDRAWN